Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner in connection with a directed share issue

Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner in connection with a directed share issue in the pharmaceutical company Xbrane Bipharma, whereby Xbrane Biopharma receives gross proceeds of approximately SEK 200 million.

Vinge has assisted STRAX in connection with a 30 MEUR facilities agreement with Proventus Capital Partners IV as lender

Vinge assisted the STRAX group in refinancing and the entering into a facilities agreement with Proventus Capital Partners IV (“Proventus”) as lender in the total amount of EUR 30 million.

Vinge advises BioGaia on directed share issue

Vinge advises BioGaia AB (publ) in connection with a directed share issue of approximately SEK 1.1 billion through an accelerated book-built offering.

Vinge advises Offentliga Hus i Norden AB (publ) in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Offentliga Hus i Norden AB (publ) (“Offentliga Hus”) in connection with its listing on Nasdaq First North Premier Growth Market (“Nasdaq First North Premier”). The prospectus was published on 13 October 2020 and the first day of trading on Nasdaq First North Premier was 23 October 2020.

Vinge advises Xspray Pharma in connection with a directed share issue

Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed share issue, whereby Xspray receives gross proceeds of approximately SEK 265 million.

Vinge advises the Swedish state in connection with the recapitalization of SAS

Vinge advises the Swedish state in connection with the recapitalization of SAS. The recapitalization plan, which includes State aid that has been approved by the EU Commission, restores SAS’ equity by SEK 14.25 billion and secures approximately SEK 12 billion of new funding.

Vinge advises Nordic Paper Holding AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Nordic Paper Holding AB (publ) (“Nordic Paper” or the “Company”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 12 October 2020 and the first day of trading on Nasdaq Stockholm was 22 October 2020.

Vinge has advised Oncopeptides in connection with entering into agreements regarding a loan facility of up to EUR 40 million from the EIB

The loan agreement with the EIB grants Oncopeptides access to an unsecured loan facility of up to EUR 40 million. The loan may be used to further support the clinical development of melflufen and the company’s transition from a R&D company into a fully integrated global biopharmaceutical company. In connection with the loan agreement, Oncopeptides has entered into a warrant agreement with the EIB, entitling the EIB to warrants in the company should the company draw on the loan facility.

Vinge advises Amasten on its offer for SSM

Vinge advises Amasten Fastighets AB (publ) in connection with its public offer to the shareholders of SSM Holding AB (publ) (“SSM”)

Vinge advises Cell Impact AB (publ) in connection with a directed share issue

Vinge has advised Cell Impact AB (publ) in connection with a directed share issue, whereby Cell Impact receives proceeds of SEK 175 million.

Vinge advises G-Loot in its half a billion SEK financing round

Vinge has advised the esports company G-Loot Global Esports AB (publ) in connection with its financing round of SEK 500 million - one of the largest esports fundraises globally.

Vinge advises Smart Eye in conjunction with a directed new issue of shares

Vinge has advised Smart Eye AB in connection with a directed new issue of 1 511 898 new shares at a subscription price of SEK 125 per share, which means that Smart Eye will acquire MSEK 189 prior to issue costs.

Vinge advises Internationella Engelska Skolan in connection with mandatory cash offer

On 25 September 2020, Grundstenen 300029 AB, owned by a consortium led by Paradigm Capital Value Fund SICAV, as well as Paradigm Capital Value LP, The Hans and Barbara Bergström Foundation, AB Tuna Holding, certain investors which are advised by Paradigm Capital AG (investment advisor to Paradigm Capital SICAV) and certain investors who have previously not been shareholders of Internationella Engelska Skolan (“IES”), announced, a mandatory cash offer to the shareholders of IES to acquire all shares in IES.

Vinge advises Bilia in conjunction with the repurchase and issuance of bonds

Vinge has advised Bilia in connection with an offer for the repurchase of previously issued bonds as well as an issue of new non‑secured bonds in the amount of MSEK 500.

Vinge advises GB HoldCo on its takeover bid for Gunnebo

Altor Fund V and Stena Adactum AB have, through the jointly controlled company GB HoldCo AB, announced a recommended cash offer to the shareholders of Gunnebo Aktiebolag. The offer values Gunnebo at approximately SEK 2.4 billion.